Neuros Medical completes $20mm Series AA round

15:40 EDT 11 Aug 2017 | Elsevier Business Intelligence

Neuromodulation company Neuros Medical Inc. (nerve-blocking device) completed a $20mm Series AA round led by US Venture Partn...

Original Article: Neuros Medical completes $20mm Series AA round


More From BioPortfolio on "Neuros Medical completes $20mm Series AA round"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...